demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID 19 hospitalized
COVID-19 severe or critically
lopinavir/ritonavir Cao REMAP-CAP ...

1 studies excluded by filtering options 2

5210 Ye et al., 2020 2990excludednot a RCTrisk of bias not avaialble